Skip to content

Clinical trials

Completed Phase 3 Angina Pectoris trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Angina Pectoris Phase: Phase 3 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20044
20054
20062
20081
20101
20112
20122
20132

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
National Heart, Lung, and Blood Institute (NHLBI)3
Organon and Co2
Pfizer2
Amarin Pharma Inc.1
Bayer1
Brigham and Women's Hospital1
Institut de Recherches Internationales Servier1
Kunming Medical University1
Lisata Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Angina Pectoris22
Coronary Artery Disease11
Myocardial Ischemia11
Heart Diseases7
Cardiovascular Diseases6
Coronary Disease6
Myocardial Infarction5
Acute Coronary Syndrome4
Ischemia4
Chest Pain3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.